🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-522915-40-00
Completed Phase I

A phase 1, Pharmacokinetic Comparison of Vonafexor Acid and Its Lysine Salt (EYP651) and Evaluation of Potential Drug-Drug Interactions.

2025-522915-40-00 · tracked via the Priya Life Science EU tracker
Sponsor
ENYO Pharma
Sponsor type
Pharmaceutical company
Therapeutic area
Digestive System Diseases
Decision date
09/10/2025
Enrollment target
40
Sites
France

Condition studied

Healthy volunteers, Impaired renal function and suspected MASH

Eligibility

Age group
18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-522915-40-00 on CTIS ↗ ← All trials in the EU